ATE100283T1 - Nahrungsmittel, angereichert mit einem gehalt an nukleosiden und/oder nukleotiden und ihre herstellung. - Google Patents

Nahrungsmittel, angereichert mit einem gehalt an nukleosiden und/oder nukleotiden und ihre herstellung.

Info

Publication number
ATE100283T1
ATE100283T1 AT88500052T AT88500052T ATE100283T1 AT E100283 T1 ATE100283 T1 AT E100283T1 AT 88500052 T AT88500052 T AT 88500052T AT 88500052 T AT88500052 T AT 88500052T AT E100283 T1 ATE100283 T1 AT E100283T1
Authority
AT
Austria
Prior art keywords
nucleotids
nucleosides
production
food enriched
enriched
Prior art date
Application number
AT88500052T
Other languages
English (en)
Inventor
Angel H Gil
Daniel V Morales
Eduardo Valverde
Original Assignee
Puleva Union Ind Agro Ganadera
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8251143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE100283(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Puleva Union Ind Agro Ganadera filed Critical Puleva Union Ind Agro Ganadera
Application granted granted Critical
Publication of ATE100283T1 publication Critical patent/ATE100283T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Saccharide Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Table Devices Or Equipment (AREA)
AT88500052T 1987-05-29 1988-05-26 Nahrungsmittel, angereichert mit einem gehalt an nukleosiden und/oder nukleotiden und ihre herstellung. ATE100283T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES8701601A ES2007350A6 (es) 1987-05-29 1987-05-29 Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
EP88500052A EP0302807B1 (de) 1987-05-29 1988-05-26 Nahrungsmittel, angereichert mit einem Gehalt an Nukleosiden und/oder Nukleotiden und ihre Herstellung

Publications (1)

Publication Number Publication Date
ATE100283T1 true ATE100283T1 (de) 1994-02-15

Family

ID=8251143

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88500052T ATE100283T1 (de) 1987-05-29 1988-05-26 Nahrungsmittel, angereichert mit einem gehalt an nukleosiden und/oder nukleotiden und ihre herstellung.

Country Status (20)

Country Link
US (2) US4994442A (de)
EP (1) EP0302807B1 (de)
JP (1) JPS6463358A (de)
AR (1) AR247975A1 (de)
AT (1) ATE100283T1 (de)
AU (2) AU1671388A (de)
CA (1) CA1338427C (de)
DE (1) DE3887226T2 (de)
ES (1) ES2007350A6 (de)
FI (1) FI882503L (de)
IE (1) IE74872B1 (de)
IL (1) IL86518A (de)
IS (1) IS3350A7 (de)
MA (1) MA21286A1 (de)
MY (1) MY103566A (de)
NO (1) NO173312C (de)
NZ (1) NZ224794A (de)
PH (1) PH26992A (de)
PT (1) PT87596B (de)
ZA (1) ZA883712B (de)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7307166B1 (en) 1987-10-28 2007-12-11 Wellstat Therapeutics Corporation Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis
JPH0394655A (ja) * 1989-09-06 1991-04-19 Otsuka Pharmaceut Co Ltd 栄養補給用組成物
EP0421309B2 (de) * 1989-10-02 2001-08-16 Novartis Nutrition AG Proteinhydrolysaten
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
JPH03164140A (ja) * 1989-11-21 1991-07-16 Sanyo Kokusaku Pulp Co Ltd 養魚用飼料組成物
DK657789D0 (da) * 1989-12-22 1989-12-22 Novo Nordisk As I naeringsmaessig henseende komplet, enteralt, diaetetisk produkt
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
DE4042115C2 (de) * 1990-12-28 1993-11-25 Milupa Ag Phenylalaninfreie Säuglings- und Kleinkindernahrungsgrundlage und Verfahren zu ihrer Herstellung
DE4102240C1 (de) * 1991-01-24 1992-04-09 Birkmayer, Joerg, Univ.-Prof. Ddr., Wien, At
US5320846A (en) * 1991-04-17 1994-06-14 New England Deaconess Hospital Corp. Method and composition for testing patients with metabolic depleting diseases
US6022853A (en) * 1991-08-30 2000-02-08 Creative Biomolecules, Inc. Morphogen-enriched dietary composition
JP3173844B2 (ja) * 1992-03-03 2001-06-04 雪印乳業株式会社 生体組織内ω３系脂肪酸増加剤及びそれを含む栄養組成物
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
GB9214247D0 (en) * 1992-07-04 1992-08-19 Stephan Peter M Composition for use as a food or food supplement
US5641759A (en) * 1993-05-26 1997-06-24 Purdue Research Foundation Animal husbandry methods and compositions therefor
US5439893A (en) * 1993-05-26 1995-08-08 University Of Montana Methods for the treatment and prevention of diarrhea
AU7319994A (en) * 1993-06-30 1995-01-24 Board Of Regents, The University Of Texas System Nucleotide preparation and uses thereof in wound healing
US6342484B1 (en) 1993-06-30 2002-01-29 Board Of Regents, The University Of Texas Systems Method and compositions for promotion of wound treatment
US5492899A (en) * 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US5700590A (en) * 1994-01-10 1997-12-23 Abbott Laboratories Nutritional formula with ribo-nucleotides
US5488039A (en) * 1994-01-10 1996-01-30 Abbott Laboratories Method for the production of an enteral formula containing ribo-nucleotides
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
AU726308B2 (en) * 1994-01-10 2000-11-02 Abbott Laboratories Enteral formula with ribo-nucleotides
NZ331481A (en) * 1994-01-10 2000-02-28 Abbott Lab Infant formula with a specific fat blend of soy, coconut, and high oleic safflower oil (HOSO), or a specified fatty acid profile of lauric, palmitic, oleic, or linleic acid
WO1995026646A1 (en) * 1994-04-01 1995-10-12 Abbott Laboratories Nutritional product for treatment of ulcerative colitis and use thereof
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5447741A (en) * 1994-04-05 1995-09-05 Goldman; Marc S. Milk composition containing fiber and method for making same
US5753295A (en) * 1994-04-05 1998-05-19 Goldman; Marc S. Non-dairy composition containing fiber and method for making same
US5558897A (en) * 1994-04-05 1996-09-24 Goldman; Marc S. Milk composition containing fiber and method for making same
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20030026782A1 (en) * 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US6241983B1 (en) 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5531989A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5656608B1 (en) * 1995-02-23 2000-09-26 Novartis Nutrition Ltd Amino acid compositions and methods of treatment using same
JP3366769B2 (ja) * 1995-03-03 2003-01-14 雪印乳業株式会社 白子を配合した栄養組成物
DK81095A (da) * 1995-07-11 1997-01-12 Henrik S Thomsen Peroralt MR-kontraststof til lever og øvre tarmkanal
US6200624B1 (en) * 1996-01-26 2001-03-13 Abbott Laboratories Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
AU3976997A (en) * 1996-08-13 1998-03-06 Bristol-Myers Squibb Company Nutritional formulas supplemented with nucleotides, and processes thereof
US6039985A (en) * 1996-11-22 2000-03-21 Princeton Nutrition, L.L.C. Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula
SA98190002B1 (ar) * 1997-03-28 2006-06-20 ذي يونيفيرسيتي اوف تننيسي ريسيرش كوربوريشن استخدام أحماض دهنية تحتوي على عدة روابط غير مشبعة polyunsaturated fatty acids لتقليل حدوث الالتهاب المعوي القولوني الناخر incidence of necrotizing enterocolitis
IL139813A0 (en) * 1998-05-22 2002-02-10 Loeb Health Res Inst At The Ot Methods and products for inducing mucosal immunity
PT1140104E (pt) * 1998-07-31 2007-12-26 Massachusetts Inst Technology Tratamento da doença de alzheimer, in vivo, por aumento dos níveis de citidina
US8518882B2 (en) * 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
US20050203053A1 (en) * 1999-07-30 2005-09-15 Wurtman Richard J. Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function
US20060069061A1 (en) * 1998-07-31 2006-03-30 Dick Wurtman Compositions containing uridine and choline, and methods utilizing same
US20070004670A1 (en) * 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6245379B1 (en) 1998-09-30 2001-06-12 The Iams Company Method of administering a milk substitute to critical care animals
EP1139793B1 (de) 1998-12-23 2009-10-14 Mount Sinai School of Medicine of New York University Hemmstoffe zur unterdrückung des bitteren geschmacks
US6120814A (en) * 1999-02-22 2000-09-19 Nature's One, Inc. Organic nutritional formula
US6194209B1 (en) * 1999-02-25 2001-02-27 Next Pharmaceuticals, Inc. Systems and methods for standardizing herbal extracts utilizing absorption studies
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6977245B2 (en) * 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
US7314716B2 (en) * 1999-11-19 2008-01-01 Mount Sinai School Of Medicine Gustducin γ subunit materials and methods
DE60131430T2 (de) * 2000-01-14 2008-10-16 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
WO2001095935A1 (en) * 2000-01-20 2001-12-20 Ottawa Health Research Institute Immunostimulatory nucleic acids for inducing a th2 immune response
SE520688C2 (sv) * 2000-04-11 2003-08-12 Bone Support Ab Ett injicerbart ersättningsmaterial för benmineral
US6566371B2 (en) * 2000-04-28 2003-05-20 University Of Pittsburgh Intraperitoneal administration of adenosine for the treatment of prevention of gastrointestinal of systemic diseases
SE517168C2 (sv) * 2000-07-17 2002-04-23 Bone Support Ab En komposition för ett injicerbart ersättningsmaterial för benmineral
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
US6511696B2 (en) 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
EP1572871A4 (de) * 2001-04-20 2007-11-14 Sinai School Medicine T1r3, ein neuer geschmacksrezeptor
US6620427B2 (en) * 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
WO2003004096A2 (en) * 2001-07-02 2003-01-16 Wisconsin Alumni Research Foundation Method and composition for prolonging the residence time of drugs in the gut
US20040192638A1 (en) * 2001-07-02 2004-09-30 Oaks John A. Method and composition for prolonging the residence time of drugs in the gut
US20030165606A1 (en) * 2001-07-18 2003-09-04 Lasekan John B. Anti-regurgitation formula and uses thereof
US7666674B2 (en) 2001-07-27 2010-02-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
AU2002361468A1 (en) 2001-08-14 2003-03-18 The Government Of The United States Of America As Represented By The Secretary Of Health And Human S Method for rapid generation of mature dendritic cells
SE522098C2 (sv) * 2001-12-20 2004-01-13 Bone Support Ab Ett nytt benmineralsubstitut
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
AU2002366710A1 (en) * 2001-12-20 2003-07-09 The Government Of The United States Of America As Represented By The Secretary Of The Department Of USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
WO2003075661A1 (en) * 2002-03-08 2003-09-18 Linguagen Corp. Oral formulations containing nucleotides that inhibit perception of unpleasant taste
CN100471502C (zh) * 2002-04-09 2009-03-25 大塚制药株式会社 细胞增殖用组合物
BR0311904A (pt) * 2002-06-19 2007-05-08 Can Technologies Inc composição de ração de animal compreendendo subproduto mucoso
US8263091B2 (en) * 2002-09-18 2012-09-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
DK1549158T3 (da) * 2002-10-10 2009-04-14 Wyeth Corp Babynæringsmiddelsammensætning indeholdende nukleotider
SE0300620D0 (sv) * 2003-03-05 2003-03-05 Bone Support Ab A new bone substitute composition
EP1608403A2 (de) * 2003-04-02 2005-12-28 Coley Pharmaceutical Group, Ltd. Immunostimulatorische nukleinsäure öl-in-wasser emulsionen zur topischen anwendung
ES2219182B1 (es) * 2003-05-12 2005-10-01 Jose Luis Concellon Martinez Procedimiento para compensar el efecto negativo en la salud de alimentos que contienen azucar refinado.
US20040258825A1 (en) * 2003-06-17 2004-12-23 Ndife Louis I. Nutritional compositions containing spray dried fiber
BRPI0414501A (pt) * 2003-09-19 2006-11-07 Nutricia Nv usos de carboidratos digerìveis solúveis em água e de um componente aumentador de guanosina-5' -trifosfato (gtp) hepático e de carboidratos digerìveis solúveis em água e de peptìdeos com atividade inibitória de ace,e, composição aquosa lìquida adequada para administração enteral
SE0302983D0 (sv) * 2003-11-11 2003-11-11 Bone Support Ab Anordning för att förse spongiöst ben med benersättnings- och/eller benförstärkningsmaterial och förfarande i samband därmed
CA2566612C (en) * 2004-05-13 2015-06-30 Massachusetts Institute Of Technology Uridine effects on dopamine release
SE527528C2 (sv) 2004-06-22 2006-04-04 Bone Support Ab Anordning för framställning av härdbar massa samt användning av anordningen
EP1634599A1 (de) * 2004-08-20 2006-03-15 N.V. Nutricia Immunstimulierende Kindernahrung
ES2537281T3 (es) * 2004-09-09 2015-06-05 Nestec S.A. Productos nutricionales de calidad mejorada y métodos y sistemas relacionados con los mismos
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
EP1776877A1 (de) * 2005-10-21 2007-04-25 N.V. Nutricia Methode zur Förderung der Darmflora
US20070114476A1 (en) * 2005-11-04 2007-05-24 Williams Christopher P Low radiocarbon nucleotide and amino acid dietary supplements
JP2009517391A (ja) * 2005-11-23 2009-04-30 アイアンウッド ファーマシューティカルズ インコーポレイテッド 胃腸障害の処置のための方法および組成物
US20070134395A1 (en) * 2005-12-13 2007-06-14 Hodges Everett L Method of reducing manganese in defatted soy isolate
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
US20070166306A1 (en) * 2006-01-17 2007-07-19 Fey Georg H M Anti-CD19 antibody composition and method
US20070254853A1 (en) * 2006-05-01 2007-11-01 Board Of Regents, The University Of Texas System Compositions and Methods for Promotion of Wound Healing
US20070280997A1 (en) * 2006-05-31 2007-12-06 Pacifichealth Laboratories, Inc. Composition for enhancing muscle recovery
US20080089981A1 (en) * 2006-10-17 2008-04-17 N.V. Nutricia Ketogenic diet
EP2158462A4 (de) 2007-05-03 2010-05-05 Radiocarb Genetics Inc Nahrungsergänzungen mit wenig radiokohlenstoff und herstellungsverfahren dafür
JP5718639B2 (ja) * 2007-08-16 2015-05-13 ザ ヘンリー エム． ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド 電離放射線誘発の損傷から哺乳類細胞を保護する方法
WO2009057994A1 (en) * 2007-11-02 2009-05-07 N.V. Nutricia Unit dosage for brain health
CA2705145A1 (en) 2007-11-07 2009-05-14 Mead Johnson Nutrition Company Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas
FR2930406B1 (fr) * 2008-04-29 2011-04-15 Groupe Lactalis Aliment infantile a base de matiere grasse d'origine laitiere
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
EP2143340A1 (de) * 2008-07-07 2010-01-13 Nestec S.A. Nährstoffzusammensetzung mit freien Aminosäuren und strukturierten Lipiden
US20100068346A1 (en) * 2008-09-16 2010-03-18 Hodges Everett L Infant formula
WO2011019641A2 (en) * 2009-08-13 2011-02-17 Nestec S.A. Nutritional compositions including exogenous nucleotides
CA2778647A1 (en) * 2009-11-25 2011-06-03 Nestec S.A. Nutritional compositions including a high protein component and exogenous nucleotides
US9180137B2 (en) 2010-02-09 2015-11-10 Bone Support Ab Preparation of bone cement compositions
CA2797716C (en) 2010-04-29 2018-09-11 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses
JP5794900B2 (ja) * 2010-11-26 2015-10-14 第一三共ヘルスケア株式会社 医薬液剤組成物
WO2012091542A1 (en) * 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
EP3510873A1 (de) 2010-12-31 2019-07-17 Abbott Laboratories Nährstoffzusammensetzungen mit oligosacchariden aus menschlicher milch und nukleotiden sowie verwendungen davon zur behandlung und/oder prävention von enteralen virusinfektionen
MY192208A (en) 2010-12-31 2022-08-08 Abbott Lab Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
NZ613180A (en) 2010-12-31 2015-02-27 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
US20120171328A1 (en) * 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
GB201205856D0 (en) * 2012-04-02 2012-05-16 Randall Jeremy A P Food supplement to support brain function
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
WO2014104872A1 (en) 2012-12-28 2014-07-03 N.V. Nutricia Method for the preparation of a liquid enteral nutritional composition comprising micellar casein
TR201807495T4 (tr) 2013-02-20 2018-06-21 Bone Support Ab Sertleştirilebilir kemik ikamesine yönelik geliştirilmiş katılaştırma.
CN105982074A (zh) * 2015-03-06 2016-10-05 内蒙古伊利实业集团股份有限公司 核苷酸组合物及其在食品中的应用
AU2020341578A1 (en) * 2019-09-05 2022-04-21 TSI Group Co. Ltd. Compositions containing adenosine triphosphate (ATP) and methods of use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3231385A (en) * 1960-12-29 1966-01-25 Takeda Chemical Industries Ltd Dairy products
GB1114190A (en) * 1965-09-11 1968-05-15 Kyowa Hakko Kogyo Company Ltd Improvements in the flavour of seasonings,beverages and foods
GB1132322A (en) * 1965-10-18 1968-10-30 Yamasa Shoyu Kk Nutrient-fortified foods and animal feeds and methods of producing and using the same
DE2619073C2 (de) * 1976-05-03 1983-01-20 Jentsch, Hans G., 4300 Essen Verfahren zur Erhöhung der Haltbarkeit von Frischmilch bei deren Abfüllen bzw. Verpacken
JPS56110617A (en) * 1980-02-08 1981-09-01 Ajinomoto Co Inc Nutrient composition for young child
US4337278A (en) * 1980-09-09 1982-06-29 Brog Roy A Imitation milk
ES507187A0 (es) * 1981-11-16 1983-01-01 Union Ind Y Agro Ganader S A U Procedimiento de obtencion de una leche humanizada adiciona-da de nucleotidos con destino a la alimentacion infantil.
JPS58216122A (ja) * 1982-06-10 1983-12-15 Meiji Milk Prod Co Ltd ヒスチジン血症乳幼児用栄養調製物
EP0107161B1 (de) * 1982-10-26 1989-08-09 CTA Finanz AG Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren
DD228951A3 (de) * 1982-12-02 1985-10-23 Inst Getreideverarbeitung Verfahren zur herstellung von granulierter nahrung
EP0129418B1 (de) * 1983-06-16 1988-10-05 Farley Health Products Limited Säuglingsnahrung
JPS60203171A (ja) * 1984-03-28 1985-10-14 Nisshin Flour Milling Co Ltd ソ−ス組成物
JPH0748991B2 (ja) * 1984-08-29 1995-05-31 日本油脂株式会社 経管栄養組成物
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula

Also Published As

Publication number Publication date
IE74872B1 (en) 1997-08-13
EP0302807A3 (en) 1990-01-17
IE881561L (en) 1988-11-29
DE3887226T2 (de) 1994-08-25
HK1006796A1 (en) 1999-03-19
MA21286A1 (fr) 1988-12-31
NO882356D0 (no) 1988-05-27
ZA883712B (en) 1989-02-22
AU1507295A (en) 1995-05-25
AR247975A1 (es) 1995-05-31
PT87596B (pt) 1995-03-01
FI882503A0 (fi) 1988-05-27
NZ224794A (en) 1991-03-26
IL86518A0 (en) 1988-11-15
FI882503A7 (fi) 1988-11-30
JPS6463358A (en) 1989-03-09
FI882503L (fi) 1988-11-30
US4994442A (en) 1991-02-19
NO882356L (no) 1988-11-30
IS3350A7 (is) 1988-11-30
PH26992A (en) 1992-12-28
NO173312B (no) 1993-08-23
NO173312C (no) 1993-12-01
IL86518A (en) 1993-01-14
CA1338427C (en) 1996-07-02
AU683980B2 (en) 1997-11-27
AU1709692A (en) 1992-07-30
ES2007350A6 (es) 1989-06-16
EP0302807A2 (de) 1989-02-08
AU1671388A (en) 1988-12-01
US5066500A (en) 1991-11-19
EP0302807B1 (de) 1994-01-19
PT87596A (pt) 1989-05-31
MY103566A (en) 1993-08-28
DE3887226D1 (de) 1994-03-03

Similar Documents

Publication Publication Date Title
ATE100283T1 (de) Nahrungsmittel, angereichert mit einem gehalt an nukleosiden und/oder nukleotiden und ihre herstellung.
DE68924026D1 (de) Biosensor und dessen herstellung.
DE3687646D1 (de) Biosensor und dessen herstellung.
DE3884095D1 (de) Polymerteilchen und ihre Herstellung.
DE3851132D1 (de) Polymerteilchen und ihre Herstellung.
DE3871544D1 (de) Parfuemierendes praeparat mit desodorierender oder schweisshemmender wirkung.
DE3784027D1 (de) Absorbierende produkte und deren herstellung.
DE3782315D1 (de) Absorbierende produkte und deren herstellung.
DE3889155D1 (de) Elektroplattierverfahren und hergestellter Gegenstand.
DE3670499D1 (de) Wasserloesliche oder in wasser dispergierbare pfropfpolymerisate, deren herstellung und verwendung.
DE3869257D1 (de) N-aminobutyl-n-phenylarylamid-derivate, ihre herstellung und ihre verwendung in der heilkunde.
DE3484531D1 (de) Tetrahydrobenzotriazole, deren herstellung und verwendung.
DE3650286D1 (de) Funktionelle Polymere und deren Herstellung.
DE3774718D1 (de) Benzothiazolylazolidine und ihre herstellung und verwendung.
DE3773722D1 (de) Inosose-derivate und ihre herstellung.
DE3771623D1 (de) Zusammengesetzte schutzstoffe, deren erzeugung und daraus hergestellte gegenstaende.
DE3382247D1 (de) Vinylcarbonsaeure-derivate, ihre herstellung und verwendung.
DE3673587D1 (de) Magnetronanode und deren herstellung.
DE3681050D1 (de) Desmutagene produkte und ihre herstellung.
DE3870764D1 (de) Anilinophenylthioharnstoffe, -isothioharnstoffe und -carbodiimide, ihre herstellung und verwendung in der schaedlingsbekaempfung.
DE3868686D1 (de) Nahrungsprodukt in form von garnelen und vorrichtung zu dessen herstellung.
DE3879328D1 (de) Stannosilikate, ihre herstellung und verwendung.
FI884123L (fi) Foerfarande foer framstaellnig av pappersmassa.
DE3787160D1 (de) Delta-hydroxy-beta-lysin-Derivate und ihre Produktion.
DE3576078D1 (de) Guanidylfunginderivate und ihre herstellung.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee